 |
 |
Dear Ivan, I think it is probable that we are being warned mot to antagonise a true friend(!). Not to go for the overkill. However, I have written to Senator Spektor myself a couple of times, and Emailed him - the last time last week, and have each time got a polite, considerate reply - even if hed did (incorrectly() identify me as one of his constituents. (My father-in-law knew him way back when, when he did advocacy work for the Postal Workers Union) Hilary Blue Ivan M Suzman wrote: > > ^^^^^^WARM GREETINGS FROM^^^^^^^^^^^^^^^^^ > Ivan Suzman 48/12 [log in to unmask] > Portland, Maine Land of lighthouses 63 deg. F sunny > ******************************************************************* > Dear Bill, > > Several of us are perplexed by one statement you made in your message. > You recommend that we do NOT contact Senator Specter. Can you please > explain why you suggest that we do NOT contact him? > > I thought that contacts with each and every Senator should be explored > whenever possible. If I were a constituent of Senator Specter, woudln't I > want to let him know of my views about full funding of the Udall Act, so > that there is a continued PD community voice for coordinated research, > all directed to curing PD? > > Does MIchael Claeys of P.A.N. or Paul Smedburg of A.P.D.A. agree or > disagree with Bill? > > Thank you all for your opinions. They are highly valued by our e-rmail > community. > > Ivan Suzman 48/12 > > On Tue, 15 Sep 1998 17:43:29 EDT "(Bill Turenne, Jr.)" > <[log in to unmask]> writes: > > ".....FY '99 APPROPRIATIONS UPDATE" > > (SNIP) > > "PLEASE DO NOT contact Senator Arlen Specter (R-PA), as he is the > Chairman of the subcommittee that wrote this bill and he is one of the > strongest advocates for increased federal investment in biomedical > research in the Congress."